+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • ID: 4775646
  • Report
  • June 2019
  • Region: Global
  • 106 pages
  • IMARC Group
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Eli Lilly & Company
  • Merck
  • Mylan NV
  • Novartis AG
  • MORE
Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such as skin and mouth patches (transdermal), gels, injections and implants. However, HRT may not be suitable for patients who have a history of blood clots, liver disease and untreated high blood pressure. This therapy may also include some adverse effects like bloating, swelling, nausea, leg cramps, headaches, indigestion, increased cholesterol levels and a rise in the number of red blood cells. According to the latest report titled “Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global hormone replacement therapy market reached a value of US$ 4.2 Billion in 2018.

A surge in the incidences of hormone imbalance disorders in the geriatric and neonatal populations is primarily driving the market growth. The rising need for new treatment options with better safety results is further boosting the demand for HRT. Additionally, aggressive marketing and direct selling campaigns by the key players along with the development of new gel-based formulations creates an attractive market for these therapies. Moreover, increasing awareness among the consumers and the presence of regularly monitored formulations are some of the other drivers stimulating the growth of the market. Looking forward, the market value is projected to reach US$ 6.3 Billion by 2024, expanding at a CAGR of 7% during 2019-2024.

Market Summary:

Based on product type, estrogen replacement therapy accounts for the majority of the market share. Other types include human growth hormone replacement therapy, testosterone replacement therapy, thyroid replacement therapy and others.

On the basis of route of administration, the report has segmented the market on the basis of oral, parenteral and transdermal segments.

On the basis of disease, the report has segmented the market on the basis of menopause, hypothyroidism, male hypogonadism, growth hormone deficiency and Others.

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the largest market, accounting for the majority of the market share.

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Bayer AG, Eli Lilly & Company, Roche, Hisamitsu Pharmaceutical Co. Inc., Merck, Mylan, Novartis, Novo Nordisk and Pfizer.

This report provides a deep insight into the global hormone replacement therapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the hormone replacement therapy market in any manner.

Key Questions Answered in This Report:

How has the global hormone replacement therapy market performed so far and how will it perform in the coming years?
What are the key regions in the global hormone replacement therapy market?
Which are the popular products in the global hormone replacement therapy market?
What are the key routes of administration in the global hormone replacement therapy market?
What are the major diseases in the global hormone replacement therapy market?
What are the various stages in the value chain of the global hormone replacement therapy market?
What are the key driving factors and challenges in the global hormone replacement therapy market?
What is the structure of the global hormone replacement therapy market and who are the key players?
What is the degree of competition in the global hormone replacement therapy market?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Bayer AG
  • Eli Lilly & Company
  • Merck
  • Mylan NV
  • Novartis AG
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Hormone Replacement Therapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Price Analysis
5.4 Market Breakup by Product
5.5 Market Breakup by Route of Administration
5.6 Market Breakup by Type of Disease
5.7 Market Breakup by Region
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Overview
5.10.2 Research and Development
5.10.3 Raw Material Procurement
5.10.4 Manufacturing
5.10.5 Marketing
5.10.6 Distribution
5.10.7 End-Use
5.11 Porters Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes

6 Market Breakup by Product
6.1 Estrogen Replacement Therapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Human Growth Hormone Replacement Therapy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Thyroid Replacement Therapy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Testosterone Replacement Therapy
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Parenteral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Transdermal
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Type of Disease
8.1 Menopause
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hypothyroidism
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Male Hypogonadism
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Growth Hormone Deficiency
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Europe
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Asia Pacific
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast

10 Competitive Landscape
10.1 Market Structure
10.2 Key Players
10.3 Profiles of Key Players
10.3.1 Abbott
10.3.2 Bayer AG
10.3.3 Eli Lilly & Company
10.3.4 Roche
10.3.5 Hisamitsu Pharmaceutical Co. Inc.
10.3.6 Merck
10.3.7 Mylan NV
10.3.8 Novartis AG
10.3.9 Novo Nordisk A/S
10.3.10 Pfizer Inc
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Bayer AG
  • Eli Lilly & Company
  • Roche
  • Hisamitsu Pharmaceutical Co. Inc.
  • Merck
  • Mylan NV
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll